Study of Orally Administered AG-881 in Patients With Advanced Solid Tu
- This topic has 0 replies, 1 voice, and was last updated 9 years ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Study of Orally Administered AG-881 in Patients With Advanced Solid Tumors, Including Gliomas, With an IDH1 and/or IDH2 Mutation
https://clinicaltrials.gov/ct2/show/NCT02481154
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.